©1996-2021 All Rights Reserved. Online Journal of Bioinformatics . You may not store these pages in any form except for your own personal use. All other usage or distribution is illegal under international copyright treaties. Permission to use any of these pages in any other way besides the before mentioned must be gained in writing from the publisher. This article is exclusively copyrighted in its entirety to OJB publications. This article may be copied once but may not be, reproduced or re-transmitted without the express permission of the editors. This journal satisfies the refereeing requirements (DEST) for the Higher Education Research Data Collection (Australia). Linking:To link to this page or any pages linking to this page you must link directly to this page only here rather than put up your own page.
Online Journal of Bioinformatics©
Volume 21(1): 21-37, 2020.
Identification of potential drug-targets in human pathogenic Clostridium perfringens SM101.
Gagan Chhabra, Pramila Sharma, Avishek Anant, Sachin Deshmukh, Himani Kaushik,
Keshav Gopal, Nutan Srivastava, Neeraj Sharma and Lalit C. Garg†
Gene Regulation Laboratory, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi – 110067, India
Chabra G, Sharma P, Anant A, Deshmukh S, Kaushik H, Gopal K, Srivastava N, Sharma N, Garg LC., Identification of potential drug-targets in human pathogen Clostridium perfringens SM101, Onl J Bioinform., Volume 21(1): 21-37, 2020. We describe comparative genome analysis of Clostridium perfringens with human genome to identify genes essential for the bacteria’s survival in non-homologous human host to identify potential drug targets. We found only 426 gene potential drug targets compared with 2558 genome’s protein coding genes. The 426 genes were further analyzed for similarity with essential genes of 14 different bacterial species present in Database of Essential Genes (DEG). We found only 5 essential genes of C. perfringens similar to those in DEG. Of these, 1 gene was similar in 12 species and 4 genes similar in 11 species. Thus, the study opens a new avenue for development of broad spectrum antibiotic against highly pathogenic bacterium by selecting these essential common genes in pathogenic microbial species. As a case study, we constructed a homology model drug target, ABC transporter-ATP binding protein, for in silico docking.
Keywords: Clostridium perfringens, DEG, Essential genes, Drug targets, Broad-spectrum antimicrobial drug.
FULL-TEXT (SUBSCRIBE OR PURCHASE TITLE)